Cresco Labs (CRLBF) Cash from Operations (2019 - 2025)
Cresco Labs (CRLBF) reported Cash from Operations of 27432000.0 for Q4 2025, down 6.97% on a YoY basis from 29486000.0 in Q4 2024, and up 345.04% quarter-over-quarter from 6164000.0 in Q3 2025.
Cresco Labs (CRLBF) Cash from Operations (2019 - 2025) Analysis & Trends
Cresco Labs has reported Cash from Operations for 7 years, with the latest figure at 27432000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 6.97% year-over-year to 27432000.0; the trailing twelve-month figure through Dec 2025 stood at 112445000.0 (down 3.21% YoY), and the FY2025 full-year result was 72890000.0, down 44.98% from the prior year.
- Cash from Operations for Q4 2025 stood at 27432000.0, up from 6164000.0 in the prior quarter.
- The five-year high for Cash from Operations was 49363000.0 in Q3 2024, with the low at 43191000.0 in Q2 2021.
- Historically, Cash from Operations has averaged 16124000.0 across 5 years, with a median of 19277000.0 in 2021.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 190.91% — and 2024, when it soared 993.24%.
- Cresco Labs' Cash from Operations stood at 37653000.0 in 2021, then plunged by 90.36% to 3631000.0 in 2022, then plunged by 190.91% to 3301000.0 in 2023, then soared by 993.24% to 29486000.0 in 2024, then decreased by 6.97% to 27432000.0 in 2025.
- The last three Cash from Operations figures came in at 27432000.0 (Q4 2025), 6164000.0 (Q3 2025), and 29486000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 125.13 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 89.36 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.43 Mn |
| Dec 31, 2025 | 27.43 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Sep 30, 2021 | 7.08 Mn |
| Sep 30, 2021 | 7.08 Mn |